COPD mortality rates in Andalusia, Spain, 1975-2010: A joinpoint regression analysis

International Journal of Tuberculosis and Lung Disease

Volumn 17, Issue 1, 2013, Pages

  López Campos, Jose Luis ^a,b   Ruiz Ramos, M ^c   Soriano, J B ^d  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c Servicio de Información y Evaluación de la Consejería de Salud de Andalucia   (Spain)

^d Laboratory of Microbial Pathogenesis   (Spain)

Author keywords

Chronic obstructive pulmonary disease; Deaths; Epidemiology

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CAUSE OF DEATH; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISEASE CLASSIFICATION; EPIDEMIOLOGICAL DATA; FEMALE; GENDER; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; REGRESSION ANALYSIS; SPAIN;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REGRESSION ANALYSIS; SPAIN; TIME FACTORS;

EID: 84871252626     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.12.0419     Document Type: Article

References (31)

1. Global Initiative for Chronic Obstructive Lung Disease I. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease, revised 2011. Bethesda, MD, USA: GOLD, 2011.
2. Mannino D M, Buist A S. Global burden of COPD: risk factors, prevalence and future trends. Lancet 2007; 370: 765-773. (Pubitemid 47321908)
3. Mathers C D, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006; 3: e442.
4. Ford E S, Mannino D M, Zhao G, Li C, Croft J B. Changes in mortality among US adults with COPD in two national cohorts recruited from 1971-1975 and 1988-1994. Chest 2012; 141: 101-110.
5. Pham T M, Ozasa K, Kubo T, et al. Age-period-cohort analysis of chronic obstructive pulmonary disease mortality in Japan, 1950-2004. J Epidemiol 2012; 22: 302-307.
6. Erbas B, Ullah S, Hyndman R J, Scollo M, Abramson M. Forecasts of COPD mortality in Australia: 2006-2025. BMC Med Res Methodol 2012; 12: 17.
7. Soriano J B, Miravitlles M, Borderias L, et al. Geographical variations in the prevalence of COPD in Spain: relationship to smoking, death rates and other determining factors. Arch Bronconeumol 2010; 46: 522-530.
8. Vestbo J, Edwards L D, Scanlon P D, et al. Changes in forced expiratory volume in 1 second over time in COPD. N Engl J Med 2011; 365: 1184-1192.
9. Banegas J R, Diez-Ganan L, Banuelos-Marco B, et al. [Smokingattributable deaths in Spain, 2006]. Med Clin (Barc) 2011; 136: 97-102. [Spanish]
10. Nowak D, Berger K, Lippert B, Kilgert K, Caeser M, Sandtmann R. Epidemiology and health economics of COPD across Europe: a critical analysis. Treat Respir Med 2005; 4: 381-395. (Pubitemid 41803325)
11. Soriano J B, Brusasco V, Dinh-Xuan A T. The European Respiratory Journal makes COPD a priority. Eur Respir J 2011; 38: 999-1001.
12. Soriano J B, Ancochea J, Miravitlles M, et al. Recent trends in COPD prevalence in Spain: a repeated cross-sectional survey 1997-2007. Eur Respir J 2010; 36: 758-765.
13. Pena V S, Miravitlles M, Gabriel R, et al. Geographic variations in prevalence and underdiagnosis of COPD: results of the IBERPOC multicentre epidemiological study. Chest 2000; 118: 981-989.
14. Kim H J, Fay M P, Feuer E J, Midthune D N. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 2000; 19: 335-351. (Pubitemid 30070608)
15. Perez-Gomez B, Aragones N, Pollan M, et al. Accuracy of cancer death certificates in Spain: a summary of available information. Gac Sanit 2006; 20 (Suppl 3): 42-51.
16. Benavides F G, Bolumar F, Peris R. Quality of death certificates in Valencia, Spain. Am J Public Health 1989; 79: 1352-1354. (Pubitemid 19239131)
17. Vollmer W M, Osborne M L, Buist A S. Uses and limitations of mortality and health care utilization statistics in asthma research. Am J Respir Crit Care Med 1994; 149 (2 Pt 2): S79-S87. (Pubitemid 24979668)
18. Calverley P M, Anderson J A, Celli B, et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 2007; 356: 775-789. (Pubitemid 46294610)
19. Drummond M B, Wise R A, John M, Zvarich M T, McGarvey L P. Accuracy of death certificates in COPD: analysis from the TORCH trial. COPD 2010; 7: 179-185.
20. Miravitlles M, Calle M, Soler-Cataluna J J. Clinical phenotypes of COPD: identification, definition and implications for guidelines. Arch Bronconeumol 2012; 48: 86-98.
21. Bakke P S, Ronmark E, Eagan T, et al. Recommendations for epidemiological studies on COPD. Eur Respir J 2011; 38: 1261-1277.
22. Miravitlles M, Soriano J B, Garcia-Rio F, et al. Prevalence of COPD in Spain: impact of undiagnosed COPD on quality of life and daily life activities. Thorax 2009; 64: 863-868.
23. Pozo-Rodriguez F, Alvarez C J, Castro-Acosta A, et al. Clinical audit of patients admitted to hospital in Spain due to exacerbation of COPD (AUDIPOC study): method and organisation. Arch Bronconeumol 2010; 46: 349-357.
24. Barnes P J. The pharmacological properties of tiotropium. Chest 2000; 117 (Suppl): 63S-66S. (Pubitemid 30111568)
25. Pauwels R A, Lofdahl C G, Laitinen L A, et al. Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease. N Engl J Med 1999; 340: 1948-1953. (Pubitemid 29288270)
26. Burge P S, Calverley P M, Jones P W, Spencer S, Anderson J A, Maslen T K. Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial. BMJ 2000; 320: 1297-1303. (Pubitemid 30245717)
27. Almagro P, Salvado M, Garcia-Vidal C, et al. Recent improvement in long-term survival after a COPD hospitalisation. Thorax 2010; 65: 298-302.
28. Cayuela A, Rodriguez-Dominguez S, López-Campos J L, Jara- Palomares L, Otero R, Vigil E. Lung cancer mortality in Spain: estimating the future burden to the year 2028. Int J Tuberc Lung Dis 2011; 15: 1117-1121.
29. Soriano J B, Maier W C, Egger P, et al. Recent trends in physician diagnosed COPD in women and men in the UK. Thorax 2000; 55: 789-794. (Pubitemid 30660909)
30. McGarvey L P, John M, Anderson J A, Zvarich M, Wise R A. Ascertainment of cause-specific mortality in COPD: operations of the TORCH Clinical Endpoint Committee. Thorax 2007; 62: 411- 415.
31. Ministerio de Sanidad y Política Social. Estrategia en EPOC del Sistema Nacional de Salud. Madrid, Spain: Ministerio de Sanidad y Política Social, 2009. [Spanish]